The Glasgow drug consumption room: A job half done?
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Medical cannabis could save NHS £4 billion each year
An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom
Compliance in the laboratory: Navigating the Controlled Substances Act and Federal Analogue Act in scientific research
Allaying the fears: Midomafetamine with therapy is a medicine
Drug Science and University College London Collaboration: Advancing MDMA-Assisted Therapy
Key Achievements of T21
Nitrous-Oxide: What is it good for?
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
Allaying the fears: MDMA with therapy is a medicine
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
“SIZE MATTERS”: High strength ecstasy pills are back, so harm reduction communications need to adapt
Kava Myths and Misunderstandings
What is Kava?
Doubt it not, MDMA is a medicine
Report of the Dutch State Committee on MDMA: A summary of findings and recommendations
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
How can we prepare psychiatry for a psychedelic future?
In defence of the decriminalisation of drug possession in the UK
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
Psilocybin shows promise in supporting symptoms of Premenstrual Dysphoric Disorder
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study